Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Fentanyl Market Size Shifted, And What Is the Outlook Through 2034?
There has been a robust growth in the market size of fentanyl in the preceding years. It is forecasted to expand from a worth of $16.22 billion in 2024 to a value of $17.15 billion in 2025, witnessing a compound annual growth rate (CAGR) of 5.7%. This upward trend in the historical stage can be linked to factors such as the requirement for pain management, medical interventions and surgeries, management of cancer-related pain, the rise in the opioid analgesic market, and the aging population.
Expectations for the fentanyl market size project a robust growth in the coming years, elevating to $22.03 billion by the year 2029, with a compound annual growth rate (CAGR) of 6.5%. The upward trend during the forecast period primarily correlates with the increasing incidences of chronic pain, the expansion in oncology treatments, a surge in surgical procedures, public health initiatives, and regulatory endorsements for new applications. Chief trends anticipated during the forecast period encompass advancements in drug compound formulations, technological innovations in its detection, public health and harm minimization strategies, a rise in pharmaceutical utilization, as well as international cooperation and data sharing.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Fentanyl Market?
The rapid rise of chronic illnesses is forecasted to fuel the expansion of the fentanyl market. Chronic diseases are medical conditions that last for at least three months or longer and often persist throughout an individual’s lifetime. Fentanyl is commonly used in chronic diseases to treat severe, long-lasting pain that cannot be effectively managed by other medications or procedures. For example, the Heart Disease Facts report, released by the Centers for Disease Control and Prevention (CDC), an American public health organization, revealed in October 2024 that coronary heart disease (CHD) in the United States was accountable for 371,506 deaths in 2022. This accounted for approximately one in every five deaths from the total of 702,880 heart disease deaths. As such, the rising prevalence of chronic diseases is a key factor driving the growth of the fentanyl market.
Which Key Market Segments Comprise the Fentanyl Market and Drive Its Revenue Growth?
The fentanyl market covered in this report is segmented –
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations
2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp
Which Areas Are Leading Regions in the Fentanyl Market Expansion Across the Globe?
North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Market Trends in theFentanyl Market Over the Coming Years?
Key businesses in the fentanyl market, such as Indivior PLC, are creating groundbreaking products like Opvee and receiving necessary approvals to cater to a broad consumer base and generate increased sales and revenue. Opvee, which contains nalmefene, is a powerful antidote for known or potential opioid overdoses caused by natural or synthetic opioids, including fentanyl. In May 2023, Indivior PLC, stationed in the US, obtained authorization from the U.S. Food and Drug Administration for their Opvee nasal spray. This product functions by neutralizing the opioid effects on the brain, thus returning respiration and blood pressure of a recently overdosed patient back to normal levels. Opvee is easy to use in emergencies since it is administered as a nasal spray. Crucially, it forms part of a suite of medicines to potently address opioid overdoses and preserve lives.
View the full report here:
https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report
How Is the Fentanyl Market Conceptually Defined?
Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model